» Articles » PMID: 11268497

Prognostic Significance of P53 Histochemistry and DNA Histogram Parameters in Head and Neck Malignancies

Overview
Journal Anticancer Res
Specialty Oncology
Date 2001 Mar 28
PMID 11268497
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of the study was to determine the role of quantitative pathological parameters in prognosis of head and neck malignancies.

Materials And Methods: 51 head and neck squamous cell carcinoma patients were examined for mutant p53 gene expression (45 out of 51 patients) by immunohistochemistry and for cellular DNA-content (44 out of 51 patients) using digital picture analyzer. Statistical analysis was performed using BMDP package.

Results: No correlation with prognosis was found for age, sex, localization, T-classification and therapy. There was significant relationship between N-status and overall survival (p = 0.0008). No correlation was found with overall and disease-free survival for either histologic type or grading. P53: No significant correlation was detected with overall survival. A relationship was found between mutant p53 and metastasis-free time (p = 0.06). Ploidy: There were no significant differences between aneuploid and euploid tumors for either disease-free or overall survival. Synthetic (S)-phase fraction: A correlation was found for both survival rates (p = 0.029) and metastasis-free time (p = 0.05). Polyploid fraction (PF): correlation was shown for both overall survival (p = 0.0128) and metastasis-free time (p = 0.0038).

Conclusion: There is correlation between p53 overexpression and metastatic potential and there is a significant relationship between SPF and PF value and prognosis (metastasis-free and overall survival) of head and neck cancer.

Citing Articles

Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.

Szentkuti G, Danos K, Brauswetter D, Kiszner G, Krenacs T, Csako L Pathol Oncol Res. 2014; 21(3):643-50.

PMID: 25547827 DOI: 10.1007/s12253-014-9869-4.


DNA content heterogeneity in neuroblastoma analyzed by means of image cytometry and its potential significance.

Melegh Z, Csernak E, Toth E, Veleczki Z, Magyarosy E, Nagy K Virchows Arch. 2005; 446(5):517-24.

PMID: 15827757 DOI: 10.1007/s00428-005-1204-8.


Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Qin L, Tang Z J Cancer Res Clin Oncol. 2004; 130(9):497-513.

PMID: 15205947 DOI: 10.1007/s00432-004-0572-9.


P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.

Qin L, Tang Z, Ma Z, Wu Z, Zhou X, Ye Q World J Gastroenterol. 2002; 8(3):459-63.

PMID: 12046070 PMC: 4656421. DOI: 10.3748/wjg.v8.i3.459.


The prognostic molecular markers in hepatocellular carcinoma.

Qin L, Tang Z World J Gastroenterol. 2002; 8(3):385-92.

PMID: 12046056 PMC: 4656407. DOI: 10.3748/wjg.v8.i3.385.